Target intelligence / Profile preview

Nematode neuromuscular junction (NMJ)

Target
NMJ
Molecular classification
Ion channel, Enzyme, Receptor, Extracellular matrix protein, Other
01

Overview

The nematode neuromuscular junction is a specialized synapse where motor neurons communicate with muscle cells via neurotransmitter release—predominantly acetylcholine and GABA in *C. elegans*. Its molecular complexity includes diverse ligand-gated ion channels (such as nicotinic acetylcholine receptors, glutamate-gated chloride channels, and GABA receptors), gap junction proteins, and associated regulatory enzymes and structural components[3][5][7][9]. This junction is the primary site for action of many anthelmintic drugs, which exploit the unique pharmacology and molecular diversity of nematode NMJ proteins to induce paralysis in parasitic worms, facilitating their elimination from the host[3][6][9]. Advances in genetics and electrophysiology have clarified the receptor and channel composition, establishing the nematode NMJ as a well-validated drug discovery platform for anti-parasitic agents[5][9]. Note: "Nematode neuromuscular junction" refers to a synaptic structure, not a single molecular entity; specific protein targets within this junction (e.g., "nicotinic acetylcholine receptor [nAChR]", "GABA receptor [unc-49]", "glutamate-gated chloride channel") should be used for structured molecular data mapping[3][5][6][9].

Other names
nematode NMJC. elegans neuromuscular junctionnematode motor synapse
02

Mechanism of action

Agonism of nicotinic acetylcholine receptors: induces sustained depolarization and spastic paralysis; Agonism of glutamate-gated chloride channels: hyperpolarization, flaccid paralysis; Inhibition of acetylcholinesterase: prolongs action of acetylcholine, leads to overstimulation; Modulation/blockade of GABA receptors and potassium channels

03

Biological functions

Signal transductionMuscle contraction and locomotionInhibition of muscle contractionOrganization of synaptic membrane domains
04

Disease associations

InfectionOther
05

Safety considerations

Off-target effects due to shared molecular mechanisms in host speciesDrug resistance (e.g., resistance to levamisole or macrocyclic lactones[6][9])Cross-resistance between drugs targeting similar receptors[3][6]
06

Interacting drugs

Levamisole

8 more in the full profile.

07

Biomarkers

Genetic mutations in receptor subunits, e.g., unc-38 or unc-29 (acetylcholine receptors)Resistance markers for nAChR-interacting drugsExpression of neuropeptide GPCRs for drug susceptibility

Beyond the preview

Go deeper on Nematode neuromuscular junction (NMJ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nematode neuromuscular junction (NMJ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call